Evidence map›Paper›PMID 37908890›Full record

ArticleActa endocrinologica (Bucharest, Romania : 2005)

CARDIOPROTECTIVE EFFECT OF DICHLOROMETHANE VALERIAN (VALERIANA OFFICINALIS) EXTRACT ON ISCHEMIA-REPERFUSION-INDUCED CARDIAC INJURIES IN RATS.

M Sedighi, H Seidi, F Asadi, H Biranvand, P Banaei, M Torkashvand, A Nazari, M Rafieian-Kopaei, P Hashemzadeh, A A Kiani and 1 more

Open access · greenAbstract read
In one paragraph

Article in Acta endocrinologica (Bucharest, Romania : 2005). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. The effect ofAvicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

M SedighiCardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences.
H SeidiLorestan University of Medical Sciences, Faculty of Pharmacy.
F AsadiLorestan University of Medical Sciences, Faculty of Pharmacy.
H BiranvandLorestan University of Medical Sciencse, Department of Physiology, Khorramabad.
P BanaeiBu Ali Sina University, Faculty of Sports Sciences, Hamadan.
M TorkashvandUniversity of Tehran, College of Engineering, Fouman Faculty of Engineering,Tehran.
A NazariCardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences.
M Rafieian-KopaeiShahrekord University of Medical Sciences, Basic Health Sciences Institute, Medical Plants Research Center, Shahrekord.
P HashemzadehLorestan University of Medical Sciences, Department of Medical Biotechnology, Faculty of Medicine, Khoramabad.
A A KianiLorestan University of Medical Sciences, Department of Hematology and Blood Transfusion, Khoramabad, Iran.
V GhorbanzadehCardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences.
Lorestan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Valepotriate is an active ingredient of valerian ( Objective: The aim of this study was to investigate the effect of an active ingredient of Methods: Thirty-two male rats were subjected to ischemia for 40 minutes and reperfusion for five days. The rats were divided into 4 groups of 8 each; group 1 (control) was given normal saline, and groups 2-4 were gavaged with 0.2, 0.1, 0.05 mg/kg of valepotriate extract, respectively, and received extract (0.2 mg/kg ip) two weeks before ischemia induction. Results: Dichloromethane Conclusion:

Indexed as

AntioxidantsCardiac injureyIschemiaQTC intervalReperfusionST segmentValepotriate

Identifiers

PMID37908890
PMCPMC10614589
OpenAlexW4387914548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.